Skip to main content
SpringerLink
Log in

Cystic Fibrosis Pulmonary Infections: The UK Experience

  • Chapter
Cystic Fibrosis Pulmonary Infections: Lessons from Around the World

Part of the book series: Respiratory Pharmacology and Pharmacotherapy ((RPP))

  • 58 Accesses

Abstract

There were over 6000 patients with cystic fibrosis resident in the United Kingdom in 1991 [1, 2]. Of these patients, 41% are over the age of 15 years, with 12% 25 years and over. The population of patients in the UK is growing at a rate of about 120 patients per year and by the end of the millennium will be over 7000 [1, 2]. By this time about 50% of patients will be over the age of 15 [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, et al. Cystic fibrosis in the United Kingdom, 1968–1988; incidence, population and survival. Paediatr Perin Epidemiol 1993; 7: 137–166.

    Google Scholar 

  2. Elborn JS, Shale DJ, Britton JR, Cystic fibrosis: Current survival and population estimates to the year 2000. Thorax 1991; 46: 881–885.

    Article  PubMed  CAS  Google Scholar 

  3. Chatfield S, Owen G, Ryley HC, Williams J, Alfaharn M, Goodchild MC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands. Clinical assessment after 5 years of screening. Arch Dis Child 1991; 66: 29–33.

    Article  PubMed  CAS  Google Scholar 

  4. Dankert-Roelse JE. Neonatal screening for cystic fibrosis. In: Dodge JA, Brock DJH, Widdecombe JIF, editors: Current Topics. London: John Wiley & Sons, 1993.

    Google Scholar 

  5. Clinical Standards Advisory Group (CSAG). Cystic Fibrosis: Access and availability of services. HMSO 1993.

    Google Scholar 

  6. Dodge JA, Goodall J, Geddes D, Littlewood JM, Mearns M, Owen JR, Russell G, et al. Cystic fibrosis in the United Kingdom 1977–85; an improving picture. Brit Med J 1988; 297: 1599–1602.

    Article  Google Scholar 

  7. The care of adults with cystic fibrosis. Roy Col Phys, London, 1992.

    Google Scholar 

  8. Oppenheimer EH, Esterly JR. Pathology of cystic fibrosis. Review of the literature and comparison with 146 autopsied cases. Prospect Pediatr Pathol 1978; 2: 241–278.

    Google Scholar 

  9. Boat TF. Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors: The metabolic basis of inherited disease. New York: McGraw Hill 1989; 2649–2680.

    Google Scholar 

  10. Oades P, Bush A. Modern management of cystic fibrosis. Matern Child Health 1992; 2: 202–207.

    Google Scholar 

  11. Weaver LT, Green MR. Nicholson K, Mills J, Heeley ME, Kuzemko JA. et al. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child 1994: 70: 84–89.

    Article  PubMed  CAS  Google Scholar 

  12. Rayner RJ, Hiller EJ, Ispahani P, Baker M. Haemophilus infection in cystic fibrosis. Arch Dis Child 1990: 65: 255–258.

    Article  PubMed  CAS  Google Scholar 

  13. Jankowskie R, Wayoff M, Lion C, Burdin JC, Foliguiet B. Virulence of Haemophihus influen_ae. In: Rigelmann R. editor. Update of Haemophilus influen_ae: how virulence. incidence and resistance affect treatment. London: Roy Soc Med Sery (Publ 128). 1988: pp 41–48.

    Google Scholar 

  14. Petersen NT. Hoiby N. Mordhorst CH. Lind K. Flensborg EW. Brunn B. Respiratory infection in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 1981: 70: 623 628.

    Google Scholar 

  15. Aitken ML. The role of mycobacterial infections in cystic fibrosis pulmonary disease. Ped Pulmonol 1991; suppl 6: 160–161.

    Google Scholar 

  16. Olivier KN, Gilligan P, Yarkaskas J. Knowles MR. Pulmonary non-tuberculous mycobacteria in cystic fibrosis. Ped Pulmonol 1992; suppl 8: 116–117.

    Google Scholar 

  17. American Thoracic Society. Treatment of tuberculosis and other mycobacterial diseases. Am Rev Respir Dis 1983; 336: 128.

    Google Scholar 

  18. Elborn JS. Shale DJ. Lung injury in cystic fibrosis. Thorax 1990: 45: 970–973.

    Article  PubMed  CAS  Google Scholar 

  19. Hoiby N. Pedersen SS. Estimated risk of cross infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 1989; 78: 395–404.

    Article  PubMed  CAS  Google Scholar 

  20. Langford D. Hiller J. Prospective controlled study of polyvalent pseudomonas vaccine in cystic fibrosis–three year results. Arch Dis Child 1984; 59: 1131–1134.

    Article  PubMed  CAS  Google Scholar 

  21. Elborn JS, Cordon SM. Shale DJ. Inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis. Pediatr Pulmonol 1993; 15: 287–291.

    Google Scholar 

  22. Steinkamp G, Tummlar B, Malottke R, Von der Hardt A. Treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis. Arch Dis Child 1989; 64: 1022–1028.

    Article  PubMed  CAS  Google Scholar 

  23. Valerius N, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338: 725–726.

    Article  PubMed  CAS  Google Scholar 

  24. Berger M. Inflammation in the lung in cystic fibrosis. Clin Rev Allergy 1990; 9: 119–142.

    Google Scholar 

  25. Hoiby N. Koch C. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax 1990; 45: 881–884.

    Article  PubMed  CAS  Google Scholar 

  26. Sakala K. Yajima H, Tanaka K. Erythromycin inhibits the producton of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. Am Rev Respir Dis 1993; 148: 1061–1065.

    Article  Google Scholar 

  27. Nelson JD. Management of acute pulmonary exacerbations in cystic fibrosis. A critical appraisal. J. Pediatr 1985; 106: 1030–1034.

    Article  PubMed  CAS  Google Scholar 

  28. Pederson SS. Jensen T. Hoiby N, Koch C, Flensborg EW. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr Scand 1987; 76: 955–961.

    Article  Google Scholar 

  29. Salh B, Bilton O. Dodd M, Abbot J. Webb K. A comparison of aztreonam and ceftazidime in adults with cystic fibrosis. Scand J Infect Dis 1992; 24: 215–218.

    Article  PubMed  CAS  Google Scholar 

  30. Norman D. Elborn JS. Cordon SM. Rayner RJ. Wiseman MS, Hiller EJ. et al. Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 1991; 46: 91–95.

    Article  PubMed  CAS  Google Scholar 

  31. Naon H, Hack S, Shelton MT, Gotthoffer RG, Gozal D, et al. Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbations in cystic fibrosis. Chest 1993; 103: 1819–1825.

    Article  PubMed  CAS  Google Scholar 

  32. Steinkamp G. Drommer A. Van der Hardt H. et al. Resting energy expenditure before and after treatment for P. aeruginosa infection in patients with cystic fibrosis. Am J Clin Nutr 1993; 57: 685–689.

    PubMed  CAS  Google Scholar 

  33. Smith A. Antibiotic resistance is not relevant in infections in cystic fibrosis. Ped Pulmonol 1990 (suppl 5 ): 93.

    Google Scholar 

  34. Moss RB. Drug allergy in cystic fibrosis. Clin Rev Allergy 1990; 9: 211–229.

    Google Scholar 

  35. Jensen T, Pedersen SS, HHiby N, Koch C. Efficacy of oral fluroquinolones versus conventional intravenous antipseudomonas chemotherapy in treatment of cystic fibrosis. Eur J Clin Microbiol 1988; 6: 618–622.

    Article  Google Scholar 

  36. Hubbard RC, McElvaney NC, Birrer P, Shak S, Robinson WW, Jolley C. et al. A preliminary study of aerosolised recombinant human deoxyribonuclease in the sputum of cystic fibrosis. N Engl J Med 1992; 326: 812–815.

    Article  PubMed  CAS  Google Scholar 

  37. Ranasinna C, Assouri B, Shak S, Christiansen D, Fuchs R, Empey D, et al. Efficacy and safety of short-term administration of aerosolised recombinant human DNase in adults with stable stage cystic fibrosis. Lancet 1993; 342: 199–202.

    Article  Google Scholar 

  38. McElvaney N, Hubbard R, Birrer P, Chernick MS, Conlan DB, Frank MM, et al. Aerosol a,-antitrypsin treatment for cystic fibrosis. Lancet 1991; 337: 392–394.

    Article  PubMed  CAS  Google Scholar 

  39. McElvaney NC, Dougall R, Moan MJ, Burnham MR, Wu MC, Crystal RG. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolised to normals and individuals with cystic fibrosis. Am Rev Respir Dis 1993; 148: 1055–1060.

    Article  Google Scholar 

  40. Hodson ME, Penketh ARC, Batten JE. Aerosol carbenicillin and gentamicin treatment of P. aeruginosa infection in patients with cystic fibrosis. Lancet 1981; ii: 1137–1135.

    Google Scholar 

  41. Littlewood JM, Miller MG, Ghoneim AT, Ramsden CH. Nebulised colomycin for early P. aeruginosa colonisation in patients with cystic fibrosis. Lancet 1985; is 865.

    Google Scholar 

  42. Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, et al. Efficacy of aerosolized tobramycin in patients wtih cystic fibrosis. N Eng J Med 1993; 328: 1740–1746.

    Article  CAS  Google Scholar 

  43. Maddison J, Dodd M, Webb K. Nebulised colistin causes chest tightness in adults with cystic fibrosis. Respir Med 1994; 88: 145–147.

    Article  PubMed  CAS  Google Scholar 

  44. Thomassen MJ, Demko CA, Doershuk CF, Stern RC, Klinger JD. Pseudomonas cepacia: Decrease in colonization in patients with cystic fibrosis. Amer Rev Resp Dis 1986; 134: 669–671.

    PubMed  CAS  Google Scholar 

  45. Govan JRW, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342: 15–19.

    Article  PubMed  CAS  Google Scholar 

  46. Editorial. Pseudomonas cepacia - more than a harmless commensal. Lancet 1992; 339: 1385–1386.

    Google Scholar 

  47. Smith DL, Smith EG, Gumery LB, Stableforth DE. Pseudomonas cepacia infection in cystic fibrosis. Lancet 1992; 339: 252.

    Article  PubMed  CAS  Google Scholar 

  48. Gladman G, Connor PJ, Williams RF, David TJ. Controlled study of P. cepacia and P. maltophilia in cystic fibrosis. Arch Dis Child 1992; 67: 192–195.

    Article  PubMed  CAS  Google Scholar 

  49. Elborn JS, Maddison J, Nelson J, Dodd M, Shale DJ, Webb KA, et al. Clinical and inflammatory responses in patients with cystic fibrosis infected with Pseudomonas aeruginosa and cepacia. Am Rev Resp Dis (Abstract) (In press).

    Google Scholar 

  50. Lewin LO, Byard PO, Davis PB. Effects of Pseudomonas cepacia colonisation on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990; 43: 125–131.

    Article  PubMed  CAS  Google Scholar 

  51. Knutsen AP, Slavin RG. Allergic bronchopulmonary in patients with cystic fibrosis. Clin Rev Allergy 1991; 9: 103–118.

    PubMed  CAS  Google Scholar 

  52. Wang EEL, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984; 311: 1653–1658.

    Article  PubMed  CAS  Google Scholar 

  53. Shale DJ. Viral infections: A role in the lung disease of cystic fibrosis? Thorax 1992; 47: 69.

    Article  PubMed  CAS  Google Scholar 

  54. Conway SP, Simmonds EJ, Littlewood JM. Acute severe deterioration in cystic fibrosis associated with Influenza A virus infection. Thorax 1992; 47: 112–114.

    Article  PubMed  CAS  Google Scholar 

  55. Petersen NT, Haiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma–possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand 1981; 70: 623–628.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adult Cystic Fibrosis Unit, Belfast City Hospital, Belfast, UK

    Stuart Elborn

  2. Department of Child Health, Queens University, Belfast, UK

    John Dodge

  3. Regional Paediatric Cystic Fibrosis Unit, St. James’ University Hospital, Leeds, S9 7TF, UK

    James Littlewood

Authors
  1. Stuart Elborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Dodge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Littlewood
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Pettenkoferstrasse 9a, D-80336, Munich, Germany

    Adolf Bauernfeind

  2. University of California at Irvine, 2801 Atlantic Avenue, 90801, Long Beach, California, USA

    Melvin I. Marks MD (Professor and Vice Chair of Pediatrics, Medical Director/Administrator) (Professor and Vice Chair of Pediatrics, Medical Director/Administrator)

  3. Long Beach Memorial Medical Center, Memorial Miller Children’s Hospital, 2801 Atlantic Avenue, 90801, Long Beach, California, USA

    Melvin I. Marks MD (Professor and Vice Chair of Pediatrics, Medical Director/Administrator) (Professor and Vice Chair of Pediatrics, Medical Director/Administrator)

  4. Department of Pediatrics, Faculty of Medicine, Göteborg University, S-416 85, Göteborg, Sweden

    Birgitta Strandvik MD, PhD (Professor of Pediatrics) (Professor of Pediatrics)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Birkhäuser Verlag, Basel, Switzerland

About this chapter

Cite this chapter

Elborn, S., Dodge, J., Littlewood, J. (1996). Cystic Fibrosis Pulmonary Infections: The UK Experience. In: Bauernfeind, A., Marks, M.I., Strandvik, B. (eds) Cystic Fibrosis Pulmonary Infections: Lessons from Around the World. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7359-8_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7359-8_26

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7361-1

  • Online ISBN: 978-3-0348-7359-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation